Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
7
Recruiting, any sponsor type, condition "acromegaly"
By trial status
The same filters, counted in each status. Pick one to switch.
7 trials
Showing 1 to 7, recently updated first.
- A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin AnalogsPivotal-lookingRecruiting
Debiopharm International SAIndustry
NCT06930625 · 119 participants (planned) · Start Nov 26, 2025 · Primary completion Jun 2028
Drug: Debio 4126; Placebo · For: Acromegaly
Sites: Los Angeles, California; Chicago, Illinois; Boston, Massachusetts · 74 sites in all
Nanjing Chia-tai Tianqing PharmaceuticalIndustry
NCT07909837 · 56 participants (planned) · Start Apr 23, 2026 · Primary completion Apr 2027
Drug: NTQ6179; NTQ6179 placebo · For: Acromegaly
Sites: Beijing, China
Camurus ABIndustry
NCT07583563 · 200 participants (planned) · Start Jun 5, 2026 · Primary completion Jun 2029
Drug: Octreotide subcutaneous depot · For: Acromegaly
Sites: Aachen, Germany; Leipzig, Germany; Magdeburg, Germany · 7 sites in all
Leiden University Medical CenterAcademic, hospital or other
NCT07866846 · 30 participants (planned) · Start Jul 29, 2025 · Primary completion Dec 31, 2027
Drug: Diabetes Medication · For: Acromegaly Due to Pituitary Adenoma; Hyperglycemia; Ketogenic Diet and 1 more
Sites: Leiden, Netherlands
Marea TherapeuticsIndustry
NCT07641179 · 72 participants (planned) · Start Jul 23, 2026 · Primary completion Aug 2027
Drug: MAR002; Placebo · For: Acromegaly
Sites: Phoenix, Arizona; Columbus, Ohio; San Antonio, Texas
- Study of MAR002 in Healthy MenRecruiting
Marea TherapeuticsIndustry
NCT07195175 · 45 participants (planned) · Start Aug 11, 2025 · Primary completion Jul 2026
Drug: MAR002; Placebo · For: Acromegaly
Sites: Tempe, Arizona
Ginkgo Leaf Center for Rare DisordersAcademic, hospital or other
NCT03158090 · 1,965 participants (planned) · Start Dec 15, 2017 · Primary completion Dec 30, 2050
Drug: sandostatin · For: Acromegaly
Sites: Guangzhou, China
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.